-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MBF1QIFPRyEbiDscAa7Fl3VfXyFlpCHRmCO41RdFiYcos8iysfhnIWMiQ2XdIq4w vBPLGAdmU7tiBSHWAjIYLg== 0001179110-04-016535.txt : 20040813 0001179110-04-016535.hdr.sgml : 20040813 20040813165746 ACCESSION NUMBER: 0001179110-04-016535 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040811 FILED AS OF DATE: 20040813 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABIOMED INC CENTRAL INDEX KEY: 0000815094 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042743260 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 22 CHERRY HILL DR CITY: DANVERS STATE: MA ZIP: 01923 BUSINESS PHONE: 9787775410 MAIL ADDRESS: STREET 1: 22 CHERRY HILL DRIVE CITY: DANVERS STATE: MA ZIP: 01923 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TERMEER HENRI A CENTRAL INDEX KEY: 0001021038 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09585 FILM NUMBER: 04975096 BUSINESS ADDRESS: STREET 1: C/O GENZYME CORP STREET 2: ONE KENDALL SQ CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6172527500 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml FORM 4 - X0202 4 2004-08-11 0 0000815094 ABIOMED INC ABMD 0001021038 TERMEER HENRI A C/O ABIOMED, INC. 22 CHERRY HILL DRIVE DANVERS MA 01923 1 0 0 0 Common Stock, $.01 par value 29551 D Common Stock, $.01 par value 2307692 I By Genzyme Corporation Stock Option (right to buy) 7.00 1998-06-30 2007-07-01 Common Stock 25000 25000 D Stock Option (right to buy) 19.69 2001-08-09 2010-08-09 Common Stock 5000 5000 D Stock Option (right to buy) 18.40 2002-08-08 2011-08-08 Common Stock 5000 5000 D Stock Option (right to buy) 4.71 2003-08-06 2013-05-21 Common Stock 5000 5000 D Common Stock (right to buy) 5.15 2004-08-13 2013-08-13 Common Stock 5000 5000 D Stock Option (right to buy) 10.41 2004-08-11 4 A 0 8000 10.41 A 2005-08-11 2014-08-11 Common Stock 8000 8000 D Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under ABIOMED, Inc. 1989 Non-Qualified Stock Option Plan for Non-Employee Directors. This option becomes exercisable in annual 20% increments commencing on the date set forth in Table II, Column 6. This option becomes exercisable in full on the date set forth in Table II, Column 6. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for the purposes of Section 16 or for any other purposes. The reporting person is the Chief Executive Officer of Genzyme Corporation. Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under ABIOMED, Inc. 2000 Stock Incentive Plan. /s/ Charles B. Haaser (attorney-in-fact) 2004-08-13 -----END PRIVACY-ENHANCED MESSAGE-----